Progressive Muscular Dystrophy clinical trials at UCLA

2 in progress, 1 open to eligible people

Showing trials for

  • AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

    open to eligible people ages 16-70

    A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

    Los Angeles, California and other locations

  • AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)

    Sorry, accepting new patients by invitation only

    A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, Efficacy, and Pharmacokinetics of AOC 1020 Administered Intravenously to Adult Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

    Los Angeles, California and other locations

Last updated: